Description: BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates in Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a dairy product. The Other segment provides animal health products. The company offers its products in the areas of baby and child care, including infantile colic, constipation, regurgitation, functional abdominal pain, and diarrhoea; gut health comprising diarrhoea and constipation; gastrointestinal health consisting of Helicobacter pylori–the gastric ulcer bacterium; and oral health, including gingivitis and periodontitis, caries, and halitosis. The company offers its products under the brand name of BioGaia through drug stores and pharmacies. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.
Home Page: www.biogaia.com
Kungsbroplan 3
Stockholm,
112 27
Sweden
Phone:
46 8 55 52 93 00
Officers
Name | Title |
---|---|
Mr. Peter Rothschild M.Sc. Econ., MBA | Founder & Chairman |
Ms. Isabelle Valerie Ghislaine Ducellier | CEO & Pres |
Mr. Alexander Kotsinas M.Sc. (Eng.). | Exec. VP & CFO |
Jens Velling | Chief Operating Officer |
Mr. Gianfranco Grompone | Chief Scientific Officer and VP of R&D |
Ms. Marika Isberg | VP of Corp. Governance - Legal, Regulatory & Sustainability |
Eva Nelson | Corp. Communications Mang. |
Ms. Linda Hagglund | VP of Marketing |
Ms. Angelika Kjelldorff | VP of HR |
Sebastian Heimfors | VP & Chief Commercial Officer |
Exchange: PINK
Country: US
Currency: US Dollar ($)
Forward PE: | 0 |
---|---|
Trailing PE: | 32.6923 |
Price-to-Book MRQ: | 4.7969 |
Price-to-Sales TTM: | 8.5616 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 195 |